Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BEAM-201 |
Synonyms | |
Therapy Description |
Limited information is currently available on BEAM-201, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD7 (Jun 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BEAM-201 | BEAM 201|BEAM201 | Limited information is currently available on BEAM-201, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD7 (Jun 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05885464 | Phase Ib/II | BEAM-201 | A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) | Recruiting | USA | 0 |